Literature DB >> 33622932

The Experience of Greece as a Model to Contain COVID-19 Infection Spread.

George J Delinasios1, Paraskevi C Fragkou2, Athina M Gkirmpa3, George Tsangaris3, Robert M Hoffman4,5, Athanasios K Anagnostopoulos1,3.   

Abstract

The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in late 2019 and has caused a pandemic known as corona virus disease 2019 (COVID-19), responsible for the death of more than 2 million people worldwide. The outbreak of COVID-19 has posed an unprecedented threat on human lives and public safety. The aim of this review is to describe key aspects of the bio-pathology of the novel disease, and discuss aspects of its spread, as well as targeted protective strategies that can help shape the outcome of the present and future health crises. Greece is used as a model to inhibit SARS-COV-2 spread, since it is one of the countries with the lowest fatality rates among nations of the European Union (E.U.), following two consecutive waves of COVID-19 pandemic. Furthermore, niche research technological approaches and scientific recommendations that emerged during the COVID-19 era are discussed. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  COVID-19; Greece; SARS-CoV-2; epidemiology; laboratory medicine; pandemic; policymaking; population screening; review; targeted protective measures

Mesh:

Year:  2021        PMID: 33622932      PMCID: PMC8045105          DOI: 10.21873/invivo.12380

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  53 in total

1.  Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.

Authors: 
Journal:  Nat Med       Date:  2020-04-23       Impact factor: 53.440

2.  Coronavirus can infect cats - dogs, not so much.

Authors:  Smriti Mallapaty
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

3.  Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020.

Authors:  Rebecca L Laws; Rebecca J Chancey; Elizabeth M Rabold; Victoria T Chu; Nathaniel M Lewis; Mark Fajans; Hannah E Reses; Lindsey M Duca; Patrick Dawson; Erin E Conners; Radhika Gharpure; Sherry Yin; Sean Buono; Mary Pomeroy; Anna R Yousaf; Daniel Owusu; Ashutosh Wadhwa; Eric Pevzner; Katherine A Battey; Henry Njuguna; Victoria L Fields; Phillip Salvatore; Michelle O'Hegarty; Jeni Vuong; Christopher J Gregory; Michelle Banks; Jared Rispens; Elizabeth Dietrich; Perrine Marcenac; Almea Matanock; Ian Pray; Ryan Westergaard; Trivikram Dasu; Sanjib Bhattacharyya; Ann Christiansen; Lindsey Page; Angela Dunn; Robyn Atkinson-Dunn; Kim Christensen; Tair Kiphibane; Sarah Willardson; Garrett Fox; Dongni Ye; Scott A Nabity; Alison Binder; Brandi D Freeman; Sandra Lester; Lisa Mills; Natalie Thornburg; Aron J Hall; Alicia M Fry; Jacqueline E Tate; Cuc H Tran; Hannah L Kirking
Journal:  Pediatrics       Date:  2020-10-08       Impact factor: 7.124

4.  Transmission of the severe acute respiratory syndrome on aircraft.

Authors:  Sonja J Olsen; Hsiao-Ling Chang; Terence Yung-Yan Cheung; Antony Fai-Yu Tang; Tamara L Fisk; Steven Peng-Lim Ooi; Hung-Wei Kuo; Donald Dah-Shyong Jiang; Kow-Tong Chen; Jim Lando; Kwo-Hsiung Hsu; Tzay-Jinn Chen; Scott F Dowell
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 5.  Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.

Authors:  Fiorella Calabrese; Federica Pezzuto; Francesco Fortarezza; Paul Hofman; Izidor Kern; Angel Panizo; Jan von der Thüsen; Sergei Timofeev; Gregor Gorkiewicz; Francesca Lunardi
Journal:  Virchows Arch       Date:  2020-07-09       Impact factor: 4.064

6.  Longitudinal symptom dynamics of COVID-19 infection.

Authors:  Barak Mizrahi; Smadar Shilo; Hagai Rossman; Nir Kalkstein; Karni Marcus; Yael Barer; Ayya Keshet; Na'ama Shamir-Stein; Varda Shalev; Anat Ekka Zohar; Gabriel Chodick; Eran Segal
Journal:  Nat Commun       Date:  2020-12-04       Impact factor: 14.919

7.  Meteorological factors, governmental responses and COVID-19: Evidence from four European countries.

Authors:  Shihua Fu; Bo Wang; Ji Zhou; Xiaocheng Xu; Jiangtao Liu; Yueling Ma; Lanyu Li; Xiaotao He; Sheng Li; Jingping Niu; Bin Luo; Kai Zhang
Journal:  Environ Res       Date:  2020-12-09       Impact factor: 6.498

8.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

9.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

Authors:  N S Zhong; B J Zheng; Y M Li; Z H Xie; K H Chan; P H Li; S Y Tan; Q Chang; J P Xie; X Q Liu; J Xu; D X Li; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

10.  COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities.

Authors:  Nia Williams; Trisha Radia; Katharine Harman; Pankaj Agrawal; James Cook; Atul Gupta
Journal:  Eur J Pediatr       Date:  2020-09-10       Impact factor: 3.183

View more
  5 in total

Review 1.  Axillary Lymph Node Swelling Mimicking Breast Cancer Metastasis After COVID-19 Vaccination: A Japanese Case Report and Literature Review.

Authors:  Nobuyasu Yoshimoto; Kohei Takura; Akemi Yanagi; Satoru Takayama; Masaki Sakamoto; Ken Ishikawa; Takeyasu Katada; Akifumi Kawate; Shoryu Takayama; Masakatsu Yamashita; Shinya Yamamoto; Kioto Yokoyama; Hisanori Kani
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Impact of the COVID-19 Pandemic on Treatment and Oncologic Outcomes for Cancer Patients in Romania.

Authors:  Oana Gabriela Trifanescu; Laurentia Gales; Xenia Bacinschi; Luiza Serbanescu; Mihai Georgescu; Alexandra Sandu; Alexandru Michire; Rodica Anghel
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Self-reported Smell and Taste Disorders in Patients With COVID-19: A Japanese Single-center Study.

Authors:  Keisuke Yamamoto; Yoshihiro Fujiya; Koji Kuronuma; Noriko Ogasawara; Tsuyoshi Ohkuni; Shin-Ichi Yokota; Satoshi Takahashi; Kenichi Takano
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

4.  Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?

Authors:  George Pavlidis; Christos F Kampolis; Garyfallia Perlepe; Athanasios Pagonis; Christos Maniotis; Emmanouil Koullias; Hariklia Kranidioti; Athanasios Kyritsis; Efthimia Pavlou; Sotirios Sinis; Maria Pirounaki; Dimitrios Vassilopoulos; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Analysis of Diagnostic Modalities in Hospital-admitted Patients Evaluated for COVID-19.

Authors:  Benedict Gereke; Andree Friedl; Jonas Rutishauser; Benedikt Wiggli; Tilo Niemann; Romana Calligaris-Maibach; Hans-Rudolf Schmid; Chiara Vanetta
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.